Official Title
Tolerability and Adverse Effects of Using Multiple Doses of Ivermectin in Egypt During Covid 19 Pandemic
Brief Summary

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Detailed Description

ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH
protocol that has been published in November 2020 the study will document the adverse effects
of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose
regimens

Status
Unknown status
Conditions
COVID19
Ivermectin Poisoning
Drug Toxicity
Drug Side Effect
Interventions

Drug: Ivermectin

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Eligibility Criteria

Inclusion Criteria:

- all people used ivermectin as a treatment or as a prophylactic in covid 19 pandemic in
egypt with explained dose

Exclusion Criteria:

-

Eligibility Gender
All
Eligibility Age
Minimum: 16 Years ~ Maximum: 80 Years
Countries
Egypt
Locations

Ahmed Mansour
Shibīn Al Kawm, Menoufia, Egypt

Sponsors / Collaborators
Menoufia University
NCT Number
NCT04747678
MeSH Terms
COVID-19
Poisoning
Drug-Related Side Effects and Adverse Reactions
Ivermectin